Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity

Journal of Bone and Mineral Research

Volumn 20, Issue 2, 2005, Pages 257-267

  Offley, Sarah C ^a   Guo, Tian Zhi ^a   Wei, Tzuping ^b,c   Clark, J David ^b,c   Vogel, Hannes ^c   Lindsey, Derek P ^d   Jacobs, Christopher R ^d,e   Yao, Wei ^f   Lane, Nancy E ^f   Kingery, Wade S ^a,c  

^a Phys Med and Rehab Service   (United States)

^b Anesthesiology   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Rehabilitation Research and Development Center   (United States)

^e Stanford University   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BMD; Bone; Calcitonin gene related peptide; Capsaicin; Osteoporosis; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE SCINTISCANNING; BONE STRENGTH; BONE STRUCTURE; CELL ACTIVITY; CELL COUNT; CELL SURFACE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; EXTRAVASATION; FEMUR; GASTROCNEMIUS MUSCLE; LOCOMOTION; MALE; METAPHYSIS; MORPHOMETRICS; MUSCLE MASS; NERVE CELL LESION; NERVE FIBER; NERVE STIMULATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PERONEUS NERVE; PROTEIN DEPLETION; RAT; SCIATIC NERVE; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SOLEUS MUSCLE; TIBIA; TRABECULAR BONE; WEIGHT BEARING;

ANIMALS; AXONS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DENSITOMETRY, X-RAY; IMMUNOENZYME TECHNIQUES; MALE; MICROSCOPY, ELECTRON; MUSCLE, SKELETAL; NEURONS; NEUROTRANSMITTER AGENTS; ORGAN SIZE; OSTEOCLASTS; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBSTANCE P; TIBIA; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 19944433023     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.041108     Document Type: Article

References (75)

1. Pearson J, Dancis J, Axelrod F, Grover N 1975 The sural nerve in familial dysautonomia. J Neuropathol Exp Neurol 34:413-424.
2. Maayan C, Bar-On E, Foldes AJ, Gesundheit B, Pollak RD 2002 Bone mineral density and metabolism in familial dysautonomia. Osteoporos Int 13:429-433.
3. Axelrod F 1995 Familial dysautonomia. In: Roberston D, Biaggion I (eds.) Disorders of the Autonomic Nervous System, vol. 5. Harwood Academic Publishers, Newark, NJ, USA, pp. 217-231.
4. Maayan C, Becker Y, Gesundheit B, Girgis SI 2001 Calcitonin gene related peptide in familial dysautonomia. Neuropeptides 35:189-195.
5. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gibert H, Skinner K, Raumann BE, Basbaum AI, Julius D 1998 The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543.
6. Helliwell RJ, McLatchie LM, Clarke M, Winter J, Bevan S, McIntyre P 1998 Capsaicin sensitivity is associated with the expression of the vanilloid (capsaicin) receptor (VR1) mRNA in adult rat sensory ganglia. Neurosci Lett 250:177-180.
7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D 1997 The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389:816-824.
8. Scadding JW 1980 The permanent anatomical effects of neonatal capsaicin on somatosensory nerves. J Anat 131:473-484.
9. Nagy JI, Iversen LL, Goedert M, Chapman D, Hunt SP 1983 Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci 3:399-406.
10. Cervero F, McRitchie HA 1982 Neonatal capsaicin does not affect unmyelinated efferent fibers of the autonomic nervous system: Functional evidence. Brain Res 239:283-288.
11. Buck SH, Burks TF 1986 The neuropharmacology of capsaicin: Review of some recent observations. Pharmacol Rev 38:179-226.
12. Virus RM, McManus DQ, Gebhart GF 1982 Capsaicin treatment in adult Wistar-Kyoto and spontaneously hypertensive rats: Effects on substance P contents of peripheral and central nervous system tissues. Eur J Pharmacol 81:67-73.
13. Helke CJ, DiMicco JA, Jacobowitz DM, Kopin IJ 1981 Effect of capsaicin administration to neonatal rats on the substance P content of discrete CNS regions. Brain Res 222:428-431.
14. Gamse R, Leeman SE, Holzer P, Lembeck F 1981 Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol 317:140-148.
15. Cuello AC, Gamse R, Holzer P, Lembeck F 1981 Substance P immunoreactive neurons following neonatal administration of capsaicin. Naunyn Schmiedebergs Arch Pharmacol 315:185-194.
16. Gamse R, Holzer P, Lembeck F 1980 Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol 68:207-213.
17. Hammond DL, Ruda MA 1991 Developmental alterations in nociceptive threshold immunoreactive calcitonin gene-related peptide and substance P, and fluoride-resistant acid phosphatase in neonatally capsaicin-treated rats. J Comp Neurol 312:436-450.
18. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
19. Ovesen J, Moller-Madsen B, Thomsen JS, Darischer G, Mosekilde L 2001 The positive effects of zinc on skeletal strength in growing rats. Bone 29:565-570.
20. Schmalbruch H 1986 Fiber composition of the rat sciatic nerve. Anat Rec 215:71-81.
21. Kalogeris TJ, Monroe F, Tso P 1997 Stimulation of intestinal apolipoprotein A-IV by lipid is independent of capsaicin-sensitive afferent signals. Am J Physiol 273:R981-R990.
22. Li Y, Song D, Zhang Y, Lee SS 2003 Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats. Gut 52:293-299.
23. Wang DH, Li J, Qiu J 1998 Salt-sensitive hypertension induced by sensory denervation: Introduction of a new model. Hypertension 32:649-653.
24. Karlsson S, Scheurink AJ, Steffens AB, Ahren B 1994 Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice. Am J Physiol 267:R1071-R1077.
25. Trudeau F, Milot M 1996 Capsaicin-sensitive nerves and endurance exercise in the rat. Physiol Behav 59:355-359.
26. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317.
27. Schicho R, Kanai Y, Ishikawa T, Skofitsch G, Donnerer J 1998 Involvement of NGF in the induction of increased noradrenergic innervation of the ureter in neonatally capsaicin-treated rats. J Auton Nerv Syst 73:46-53.
28. Marfurt CF, Ellis LC, Jones MA 1993 Sensory and sympathetic nerve sprouting in the rat cornea following neonatal administration of capsaicin. Somatosens Mot Res 10:377-398.
29. Terenghi G, Zhang SQ, Unger WG, Polak JM 1986 Morphological changes of sensory CGRP-immunoreactive and sympathetic nerves in peripheral tissues following chronic denervation. Histochemistry 86:89-95.
30. Kingery WS, Guo TZ, Davies MF, Limbird L, Maze M 2000 The alpha2 adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice. Pain 85:345-358.
31. Kingery WS, Offley SC, Guo TZ, Davies MF, Clark JD, Jacobs CR 2003 A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone 33:927-936.
32. Goto T, Tanaka T 2002 Tachykinins and tachykinin receptors in bone. Microsc Res Tech 58:91-97.
33. Imai S, Matsusue Y 2002 Neuronal regulation of bone metabolism and anabolism: Calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc Res Tech 58:61-69.
34. Bjurholm A 1991 Neuroendocrine peptides in bone. Int Orthop 15:325-329.
35. Hukkanen M, Konttinen YT, Rees RG, Santavirta S, Terenghi G, Polak JM 1992 Distribution of nerve endings and sensory neuropeptides in rat synovium, meniscus and bone. Int J Tissue React 14:1-10.
36. Hukkanen M, Konttinen YT, Rees RG, Gibson SJ, Santavirta S, Polak JM 1992 Innervation of bone from healthy and arthritic rats by substance P and calcitonin gene related peptide containing sensory fibers. J Rheumatol 19:1252-1259.
37. Goto T, Yamaza T, Kido MA, Tanaka T 1998 Light- and electron-microscopic study of the distribution of axons containing substance P and the localization of neurokinin-1 receptor in bone. Cell Tissue Res 293:87-93.
38. Irie K, Hara-Irie F, Ozawa H, Yajima T 2002 Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech 58:85-90.
39. Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O'Leary P, Mantyh PW 2002 Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur. Neuroscience 113:155-166.
40. Imai S, Tokunaga Y, Maeda T, Kikkawa M, Hukuda S 1997 Calcitonin gene-related peptide, substance P, and tyrosine hydroxylase-immunoreactive innervation of rat bone marrows: An immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms. J Orthop Res 15:133-140.
41. Zerari F, Dery O, Fischer J, Frobert Y, Couraud JY, Conrath M 1995 Ultrastructural study of substance P receptors in the dorsal horn of the rat spinal cord using monoclonal anticomplementary peptide antibody. J Chem Neuroanat 9:65-77.
42. Burgoyne RD, Morgan A 2003 Secretory granule exocytosis. Physiol Rev 83:581-632.
43. Zupanc GK 1996 Peptidergic transmission: From morphological correlates to functional implications. Micron 27:35-91.
44. Togari A 2002 Adrenergic regulation of bone metabolism: Possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58:77-84.
45. Shih C, Bernard GW 1997 Neurogenic substance P stimulates osteogenesis in vitro. Peptides 18:323-326.
46. Adamus MA, Dabrowski ZJ 2001 Effect of the neuropeptide substance P on the rat bone marrow-derived osteogenic cells in vitro. J Cell Biochem 81:499-506.
47. D'Souza SM, MacIntyre I, Girgis SI, Mundy GR 1986 Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro. Endocrinology 119:58-61.
48. Roos BA, Fischer JA, Pignat W, Alander CB, Raisz LG 1986 Evaluation of the in vivo and in vitro calcium-regulating actions of noncalcitonin peptides produced via calcitonin gene expression. Endocrinology 118:46-51.
49. Yamamoto I, Kitamura N, Aoki J, Shigeno C, Hino M, Asonuma K, Torizuka K, Fujii N, Otaka A, Yajima H 1986 Human calcitonin gene-related peptide possesses weak inhibitory potency of bone resorption in vitro. Calcif Tissue Int 38:339-341.
50. Zaidi M, Fuller K, Bevis PJ, Gainesdas RE, Chambers TJ, MacIntyre I 1987 Calcitonin gene-related peptide inhibits osteoclastic bone resorption: A comparative study. Calcif Tissue Int 403:149-154.
51. Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P 2000 Effects of CGRP on human osteoclast-like cell formation: A possible connection with the bone loss in neurological disorders? Peptides 21:559-564.
52. Bjurholm A, Kreicbergs A, Schultzberg M, Lerner UH 1992 Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res 7:1011-1019.
53. Michelangeli VP, Fletcher AE, Allan EH, Nicholson GC, Martin TJ 1989 Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells. J Bone Miner Res 4:269-272.
54. Tamura T, Miyaura C, Owan I, Suda T 1992 Mechanism of action of amylin in bone. J Cell Physiol 153:6-14.
55. Kawase T, Howard GA, Roos BA, Burns DM 1995 Diverse actions of calcitonin gene-related peptide on intracellular free Ca2+ concentrations in UMR 106 osteoblastic cells. Bone 16(4 Suppl):379S-384S.
56. Bernard GW, Shih C 1990 The osteogenic stimulating effect of neuroactive calcitonin gene-related peptide. Peptides 11:625-632.
57. Shih C, Bernard GW 1997 Calcitonin gene related peptide enhances bone colony development in vitro. Clin Orthop 334:335-344.
58. Valentijn K, Gutow AP, Troiano N, Gundberg C, Gilligan JP, Vignery A 1997 Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone 21:269-274.
59. Hill EL, Turner R, Eide R 1991 Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 44:747-755.
60. Adam C, Llorens A, Baroukh B, Cherruau M, Saffar JL 2000 Effects of capsaicin-induced sensory denervation on osteoclastic resorption in adult rats. Exp Physiol 85:62-66.
61. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M 2004 CD40-CD40L expression during orthodontic tooth movement in rats. Angle Orthod 74:100-105.
62. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M 2001 Orthodontic tooth movement and de novo synthesis of proinflammatory cytokines. Am J Orthod Dentofacial Orthop 119:307-312.
63. Levite M 2000 Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann NY Acad Sci 917:307-321.
64. Gendek-Kubiak H, Danowski J, Kmiec BL 2003 A morphological and immunohistochemical investigation of guinea pig skin after the introduction of substance P and VIP. Cell Mol Biol Lett 8:63-67.
65. Delgado AV, McManus AT, Chambers JP 2003 Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37:355-361.
66. Guo CJ, Lai JP, Luo HM, Douglas SD, Ho WZ 2002 Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes. J Neuroimmunol 131:160-167.
67. Horowitz MC, Lorenzo JA 2001 Local regulators of bone. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, pp. 961-978.
68. Nanes MS 2003 Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology. Gene 321:1-15.
69. Scott C, Perry MJ, Raven PE, Massey EJ, Lisney SJ 2000 Capsaicin-sensitive afferents are involved in signalling transneuronal effects between cutaneous sensory nerves. Neuroscience 95:535-541.
70. Kingery WS, Castellote JM, Maze M 1999 Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds. Pain 80:555-566.
71. Kingery WS, Guo TZ, Agashe GS, Davies MF, Clark JD, Maze M 2001 Glucocorticoid inhibition of neuropathic limb edema and cutaneous neurogenic extravasation. Brain Res 913:140-148.
72. Manolagas SC, Weinstein RS 1999 New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14:1061-1066.
73. Bergman E, Johnson H, Zhang X, Hokfelt T, Ulfhake B 1996 Neuropeptides and neurotrophin receptor mRNAs in primary sensory neurons of aged rats. J Comp Neurol 375:303-319.
74. Kiebzak GM, Smith R, Gundberg CC, Howe JC, Sacktor B 1988 Bone status of senescent male rats: Chemical, morphometric, and mechanical analysis. J Bone Miner Res 3:37-45.
75. Wang L, Banu J, McMahan CA, Kalu DN 2001 Male rodent model of age-related bone loss in men. Bone 29:141-148.